Sulfonylurea monotherapy ups CVD risk vs. metformin in older diabetics

June 26, 2011

Older patients started on oral antidiabetic therapy with a sulfonylurea have significantly higher risk for cardiovascular disease (CVD) events than patients started on metformin.